Oncology & Cancer
Development of a novel bispecific antibody therapy to overcome myeloma heterogeneity
Multiple myeloma is still an incurable hematological malignancy. One of the reasons is that myeloma cells can be heterogenous and acquire resistance after anti-myeloma treatment. Immunotherapy is an attractive strategy to ...
Nov 17, 2023
0
1